|
End-of-day quote
Korea S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 4,705.00 KRW | +11.49% |
|
-13.99% | -31.61% |
| 09-20 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| 08-14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +11.49% | -13.99% | +38.18% | +21.26% | -31.61% | +67.74% | -28.71% | -74.11% | - | 164M | |
| -6.60% | -10.93% | -7.90% | +9.73% | +59.20% | +45.08% | +60.01% | -0.71% | - | 68.98B | |
| -4.09% | -0.11% | -14.26% | -3.01% | +1.51% | +2.31% | +54.81% | +187.36% | +4,783.22% | 53.15B | |
| +0.03% | +5.56% | +12.18% | +5.01% | +12.31% | +10.18% | +41.75% | -16.57% | +233.70% | 50.83B | |
| -1.04% | +3.31% | -0.12% | +27.56% | +19.11% | +30.50% | +34.94% | +8.06% | +256.66% | 44.61B | |
| -5.80% | -6.08% | -9.03% | -0.54% | +123.75% | +258.74% | +422.33% | +536.50% | - | 40.57B | |
| -1.54% | +4.12% | +6.03% | +16.27% | +21.48% | +16.05% | +112.18% | +2.29% | +1,034.55% | 42.53B | |
| +6.53% | +8.02% | +9.30% | +10.42% | +12.54% | +18.98% | +54.58% | +7.26% | +169.34% | 30.95B | |
| -0.90% | -10.91% | -2.07% | +21.90% | +53.31% | +34.11% | -1.83% | -55.94% | - | 25.44B | |
| -2.33% | -9.02% | -7.95% | -3.66% | -7.34% | -16.05% | -9.03% | -66.21% | - | 22.66B | |
| -1.07% | +2.33% | +13.16% | +32.35% | +23.43% | +17.24% | +11.20% | -12.27% | +123.99% | 22.65B | |
| -2.49% | -3.85% | -21.09% | -9.99% | -44.42% | -40.73% | +285.69% | +266.96% | +611.77% | 21.67B | |
| -1.87% | +0.50% | -0.21% | +14.35% | +9.52% | +18.02% | +159.25% | +231.03% | +1,985.14% | 17.55B | |
| +3.32% | +4.18% | +3.32% | -5.68% | +193.84% | +168.17% | +386.54% | +1,614.31% | +817.72% | 15.42B | |
| -1.27% | +3.94% | +9.58% | +11.75% | +41.96% | +58.68% | +188.46% | +191.98% | +440.57% | 15.57B | |
| -1.14% | +1.48% | +4.77% | +12.60% | +25.42% | +23.28% | +55.28% | -28.67% | +86.96% | 15.4B | |
| -0.30% | -1.44% | -8.79% | -13.04% | - | - | - | - | - | 14.88B | |
| -1.32% | +0.26% | +10.67% | +32.04% | +51.68% | +72.95% | +56.99% | -26.91% | +277.99% | 14.62B | |
| +3.10% | +1.39% | -2.25% | -15.75% | +15.25% | -3.54% | +445.89% | - | - | 13.35B | |
| -1.50% | +5.21% | -0.70% | +1.60% | -5.21% | -8.35% | -29.54% | -37.55% | +123.44% | 13.51B | |
| Average | -0.45% | +1.91% | +1.64% | +8.26% | +30.30% | +40.70% | +121.09% | +151.49% | +841.93% | 27.23B | |
| Weighted average by Cap. | -1.84% | +2.18% | -1.18% | +8.46% | +33.62% | +41.52% | +112.23% | +125.27% | +1,127.71% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
